TY - JOUR
T1 - Accuracy of intraocular lens power calculation in patients with endothelial dystrophy without edema
AU - Shemer, Asaf
AU - Fradkin, Maayan
AU - Dubinsky-Pertzov, Biana
AU - Reitblat, Olga
AU - Simaan, Francis
AU - Sella, Ruti
AU - Pras, Eran
AU - Einan-Lifshitz, Adi
N1 - Publisher Copyright:
© 2024 Published by Wolters Kluwer on behalf of ASCRS and ESCRS.
PY - 2024
Y1 - 2024
N2 - Purpose:To evaluate the accuracy of several intraocular lens (IOL) formulas for patients with endothelial dystrophy (ED) without edema treated with cataract surgery aloneSetting:One academic, tertiary referral center.Design:Comparative retrospective cohort study.Methods:We assessed the predicted refractive results of ED patients who underwent cataract surgery and compared them to a matched control group. The accuracy of five different IOL formulas Haigis, Holladay 1, Barrett Universal II, SRK/T and Kane was evaluated and compared between the groups. The standard deviations of the prediction error of all formulas were compared.Results:The study included 221 eyes. Fifty (23%) eyes of patients with ED and 171 (77%) control eyes. There was no significant difference between the two groups in clinical and demographical characteristics (P>0.05). The postoperative spherical equivalent was -0.37 D in the ED group and -0.30 D in the control group (P=0.8). Overall, both groups had a comparable standard deviation of the prediction error (PE) and absolute PE (APE) in all formulas (p>0.05). In the ED group, APE was 0.34 D for Haigis, 0.32 D for Holladay1, 0.32 D for Barrett Universal II, 0.38 D for SRK/T and 0.32 D for Kane formulas. No statistically significant difference between formulas was found.Conclusion:The prediction accuracy of IOL power calculation in patients with ED was found comparable both between formulas and in comparison with healthy controls. This suggests that in patients with guttate without edema the IOL power calculations are as effective and accurate as in healthy eyes.
AB - Purpose:To evaluate the accuracy of several intraocular lens (IOL) formulas for patients with endothelial dystrophy (ED) without edema treated with cataract surgery aloneSetting:One academic, tertiary referral center.Design:Comparative retrospective cohort study.Methods:We assessed the predicted refractive results of ED patients who underwent cataract surgery and compared them to a matched control group. The accuracy of five different IOL formulas Haigis, Holladay 1, Barrett Universal II, SRK/T and Kane was evaluated and compared between the groups. The standard deviations of the prediction error of all formulas were compared.Results:The study included 221 eyes. Fifty (23%) eyes of patients with ED and 171 (77%) control eyes. There was no significant difference between the two groups in clinical and demographical characteristics (P>0.05). The postoperative spherical equivalent was -0.37 D in the ED group and -0.30 D in the control group (P=0.8). Overall, both groups had a comparable standard deviation of the prediction error (PE) and absolute PE (APE) in all formulas (p>0.05). In the ED group, APE was 0.34 D for Haigis, 0.32 D for Holladay1, 0.32 D for Barrett Universal II, 0.38 D for SRK/T and 0.32 D for Kane formulas. No statistically significant difference between formulas was found.Conclusion:The prediction accuracy of IOL power calculation in patients with ED was found comparable both between formulas and in comparison with healthy controls. This suggests that in patients with guttate without edema the IOL power calculations are as effective and accurate as in healthy eyes.
KW - Formula
KW - Fuchs
KW - IOL calculations
KW - endothelial corneal dystrophy
KW - guttate
KW - intraocular lens
UR - http://www.scopus.com/inward/record.url?scp=85209406220&partnerID=8YFLogxK
U2 - 10.1097/j.jcrs.0000000000001578
DO - 10.1097/j.jcrs.0000000000001578
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 39501467
AN - SCOPUS:85209406220
SN - 0886-3350
JO - Journal of Cataract and Refractive Surgery
JF - Journal of Cataract and Refractive Surgery
M1 - 10.1097/j.jcrs.0000000000001578
ER -